Ifp Advisors, Inc Citius Pharmaceuticals, Inc. Transaction History
Ifp Advisors, Inc
- $2.91 Billion
- Q4 2024
A detailed history of Ifp Advisors, Inc transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 33,333 shares of CTXR stock, worth $84,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,333
Previous 33,333
-0.0%
Holding current value
$84,999
Previous $16,000
731.25%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CTXR
# of Institutions
46Shares Held
23.1MCall Options Held
83.1KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY7.28MShares$18.6 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$16.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$4.79 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$4.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$2.95 Million0.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $373M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...